Table 2.

Genomic regions significantly and consistently hypermethylated or hypomethylated in SUP, OMA, and DIE, as compared with EE

Chromosome	No. active region	Start	Length	Ratio SUP/EE	Ratio OMA/EE	Ratio DIE/EE	Gene symbol	Gene name
2	1466	242661047	1477	0.52	0.29	0.59	FLJ38379	Hypothetical protein FLJ38379
2	1467	242662876	1138	0.62	0.40	0.39	FLJ38379	Hypothetical protein FLJ38379
2	1470	131249876	565	0.43	0.36	0.41	DEFB125	Defensin, β 125
3	1728	122953778	587	0.60	0.59	0.60	GOLGB1	Golgin B1, Golgi integral membrane protein
5	1896	763481	1315	0.37	0.65	0.60
5	1911	1669770	393	0.55	0.35	0.52
5	1999	170219671	206	0.44	0.62	0.59
6	2091	138477515	243	0.66	0.60	0.57	PERP	TP53 apoptosis effector
7	2186	56207807	8821	1.54	1.61	1.91
7	2263	156232815	1524	3.10	3.06	2.16	NOM1	Nucleolar protein with MIF4G domain 1
9	2396	17261249	762	0.64	0.65	0.60	CNTLN	Centlein, centrosomal protein
10	224	44815659	252	2.05	2.19	1.82	RASSF4	ras Association (RalGDS/AF-6) domain family member 4
10	224	44815659	252	2.05	2.19	1.82	C10orf25	Chromosome 10 open reading frame 25
10	224	44815659	252	2.05	2.19	1.82	ZNF22	Zinc finger protein 22 (KOX 15)
11	310	520194	1229	1.69	2.58	1.83	HRAS	v-Ha-ras Harvey rat sarcoma viral oncogene homolog
11	310	520194	1229	1.69	2.58	1.83	LRRC56	Leucine-rich repeat containing 56
13	558	112809520	1027	1.83	2.47	2.03	F7	Coagulation factor VII (serum prothrombin conversion accelerator)
13	561	113114806	556	2.30	2.44	1.52	DKFZp451A211	DKFZp451A211 protein
13	561	113114806	556	2.30	2.44	1.52	ADPRHL1	ADP-ribosylhydrolase like 1
16	735	1250431	492	1.57	1.59	1.67	TPSD1	tryptase δ 1
16	815	31142886	513	1.63	1.71	1.64	PYDC1	PYD (pyrin domain) containing 1
17	986	54115047	229	0.51	0.56	0.66	TEX14	Testis expressed 14
17	986	54115047	229	0.51	0.56	0.66	RAD51C	RAD51 homolog C (S. cerevisiae)
19	1136	617852	1086	2.38	1.85	1.58	RNF126	Ring finger protein 126
19	1136	617852	1086	2.38	1.85	1.58	FSTL3	Follistatin-like 3 (secreted glycoprotein)
X	2538	37114623	597	0.53	0.55	0.58	FTHL19	Ferritin, heavy polypeptide-like 19

Regions with a ratio above 1.50 or below 0.66 were taken into consideration.